About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT00831337

Evaluation of Probiotics in the Treatment of Portal Hypertension

This study is to evaluate the role of probiotics in the treatment of portal hypertension. In particular the role of probiotics on gut microbiota in liver cirrhosis patients will be studied and compare...

Lead sponsor: Pomeranian Medical University Szczecin•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pomeranian Medical University Szczecin

Studied probiotics: VSL3

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Confirmed liver cirrhosis (liver biopsy or typical imaging studies)
•Confirmed portal hypertension
•18 years and older
•compliant patients

Exclusion Criteria

•Antibiotic treatment in last 3 months
•Lactulose treatment in last 3 months
•Patients taking NSAIDS in lat 3 months
•Steroid treatment in last 3 months
•Ongoing and active infection
•Pregnant woman
•Cancer diagnosis
•decompensated diabetes mellitus
•active or past treatment with recombinant cytokines (e.g. anty TNF, interferon etc)
•medication altering function of CNS, suffering from neurological or ophthalmological conditions
•initiating the therapy with beta blockers within the prior 12 weeks
•mental disease

Related studies

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

NCT01730131 · Progressive Multifocal Leukoencephalopathy

RECRUITINGPhase 3

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

NCT07019922 · Epileptic Encephalopathy, SCN2A Encephalopathy

Microplastics, Cirrhosis and Portal Hypertension

NCT07280390 · Cirrhosis, Microplastics, and more

Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices

NCT07358663 · Esophagogastric Varices, Portal Hypertension

Natural History of Noncirrhotic Portal Hypertension

NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 23, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment33

Start dateApr 2007

Last updatedNov 23, 2016

Condition

Liver Cirrhosis Portal Hypertension Encephalopathy

Locations shown

Department of Gastroenterology, Pomeranian Medical University

Szczecin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 23, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions